Arabic Arabic English English French French German German
dark

CohBar Appoints Joseph J. Sarret, M.D., J.D. as Chief Executive Officer and DirectorAnnounces change to the Board of Director’s Chair

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced the appointment of Joseph J. Sarret, M.D., J.D. as Chief Executive Officer and Director, effective May 3, 2021. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

No new community cases; 8 cases of COVID-19 in managed isolation in 2 days

Next Post

Bench International Expands West Coast Presence with Linda Sierra

Related Posts
Total
0
Share